{
  "company_number": "07650983",
  "name": "Seacross Pharmaceuticals Ltd",
  "url": "/company/07650983",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2011-05-31",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "21200",
      "description": "Manufacture of pharmaceutical preparations",
      "section": "C",
      "section_name": "Manufacturing",
      "url": "/sic/21200"
    }
  ],
  "registered_address": {
    "id": 540009,
    "url": "/address/540009",
    "line1": "BEDFORD BUSINESS CENTRE",
    "line2": "61-63 ST PETERS STREET",
    "post_town": "BEDFORD",
    "county": "BEDFORDSHIRE",
    "country": "",
    "postcode": "MK40 2PR"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07650983",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2026-09-30",
    "last_made_up": "2024-12-31",
    "category": "SMALL",
    "filings": [
      {
        "url": "/company/07650983/accounts/2024-12-31",
        "pdf_url": "/company/07650983/accounts/2024-12-31.pdf",
        "made_up_date": "2024-12-31",
        "period_start": "2024-12-31",
        "period_end": "2024-12-31",
        "entity_name": "Seacross Pharmaceuticals Ltd",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "1368437.00",
        "debtors": "2013245.00",
        "cash_bank_in_hand": "3875846.00",
        "current_assets": "7898183.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "760429.00",
        "total_assets_less_current_liabilities": "2128866.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6000000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2025.zip"
      },
      {
        "url": "/company/07650983/accounts/2023-12-31",
        "pdf_url": "/company/07650983/accounts/2023-12-31.pdf",
        "made_up_date": "2023-12-31",
        "period_start": "2023-12-31",
        "period_end": "2023-12-31",
        "entity_name": "Seacross Pharmaceuticals Ltd",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "1809167.00",
        "debtors": "2201836.00",
        "cash_bank_in_hand": "3231883.00",
        "current_assets": "6441946.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "2090937.00",
        "total_assets_less_current_liabilities": "3900104.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6000000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2024.zip"
      },
      {
        "url": "/company/07650983/accounts/2022-12-31",
        "pdf_url": "/company/07650983/accounts/2022-12-31.pdf",
        "made_up_date": "2022-12-31",
        "period_start": "2022-12-31",
        "period_end": "2022-12-31",
        "entity_name": "Seacross Pharmaceuticals Ltd",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "1971985.00",
        "debtors": "2113397.00",
        "cash_bank_in_hand": "3123904.00",
        "current_assets": "6347322.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "1277784.00",
        "total_assets_less_current_liabilities": "3249769.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6000000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2023.zip"
      },
      {
        "url": "/company/07650983/accounts/2021-12-31",
        "pdf_url": "/company/07650983/accounts/2021-12-31.pdf",
        "made_up_date": "2021-12-31",
        "period_start": "2021-12-31",
        "period_end": "2021-12-31",
        "entity_name": "Seacross Pharmaceuticals Ltd",
        "dormant": false,
        "average_employees": "5.00",
        "tangible_fixed_assets": "2137472.00",
        "debtors": "1243434.00",
        "cash_bank_in_hand": "2327962.00",
        "current_assets": "4329897.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "436937.00",
        "total_assets_less_current_liabilities": "2574409.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6000000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2022.zip"
      },
      {
        "url": "/company/07650983/accounts/2020-12-31",
        "pdf_url": "/company/07650983/accounts/2020-12-31.pdf",
        "made_up_date": "2020-12-31",
        "period_start": "2020-12-31",
        "period_end": "2020-12-31",
        "entity_name": "Seacross Pharmaceuticals Ltd",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "1038567.00",
        "debtors": "1894181.00",
        "cash_bank_in_hand": "453213.00",
        "current_assets": "5180627.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "794849.00",
        "total_assets_less_current_liabilities": "1833416.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6000000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2021.zip"
      },
      {
        "url": "/company/07650983/accounts/2019-12-31",
        "pdf_url": "/company/07650983/accounts/2019-12-31.pdf",
        "made_up_date": "2019-12-31",
        "period_start": "2019-12-31",
        "period_end": "2019-12-31",
        "entity_name": "Seacross Pharmaceuticals Ltd",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "1166628.00",
        "debtors": "9269568.00",
        "cash_bank_in_hand": "715399.00",
        "current_assets": "10288167.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "502446.00",
        "total_assets_less_current_liabilities": "1669074.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6000000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2020.zip"
      },
      {
        "url": "/company/07650983/accounts/2018-12-31",
        "pdf_url": "/company/07650983/accounts/2018-12-31.pdf",
        "made_up_date": "2018-12-31",
        "period_start": "2018-12-31",
        "period_end": "2018-12-31",
        "entity_name": "Seacross Pharmaceuticals Ltd",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "1298850.00",
        "debtors": "5037978.00",
        "cash_bank_in_hand": "145606.00",
        "current_assets": "5577076.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-431234.00",
        "total_assets_less_current_liabilities": "867616.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "6000000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2019.zip"
      },
      {
        "url": "/company/07650983/accounts/2013-12-31",
        "pdf_url": "/company/07650983/accounts/2013-12-31.pdf",
        "made_up_date": "2013-12-31",
        "period_start": "2013-12-31",
        "period_end": "2013-12-31",
        "entity_name": "Seacross Pharmaceuticals Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "1136123.00",
        "debtors": "71905.00",
        "cash_bank_in_hand": "393937.00",
        "current_assets": "813204.00",
        "creditors_due_within_one_year": "1126017.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-312813.00",
        "total_assets_less_current_liabilities": "823310.00",
        "net_assets_liabilities": "823310.00",
        "called_up_share_capital": "3000000.00",
        "profit_loss_account_reserve": "-2176690.00",
        "shareholder_funds": "823310.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2014.zip"
      },
      {
        "url": "/company/07650983/accounts/2012-12-31",
        "pdf_url": "/company/07650983/accounts/2012-12-31.pdf",
        "made_up_date": "2012-12-31",
        "period_start": "2012-12-31",
        "period_end": "2012-12-31",
        "entity_name": "Seacross Pharmaceuticals Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "336413.00",
        "debtors": "30382.00",
        "cash_bank_in_hand": "899860.00",
        "current_assets": "930242.00",
        "creditors_due_within_one_year": "173097.00",
        "creditors_due_after_one_year": "0.00",
        "net_current_assets_liabilities": "757145.00",
        "total_assets_less_current_liabilities": "1093558.00",
        "net_assets_liabilities": "1093558.00",
        "called_up_share_capital": "1500100.00",
        "profit_loss_account_reserve": "-406542.00",
        "shareholder_funds": "1093558.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2013.zip"
      },
      {
        "url": "/company/07650983/accounts/2011-12-31",
        "pdf_url": "/company/07650983/accounts/2011-12-31.pdf",
        "made_up_date": "2011-12-31",
        "period_start": "2011-12-31",
        "period_end": "2011-12-31",
        "entity_name": "Seacross Pharmaceuticals Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": "35009.00",
        "cash_bank_in_hand": "1501180.00",
        "current_assets": "1536189.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "1417220.00",
        "total_assets_less_current_liabilities": "1417220.00",
        "net_assets_liabilities": "1417220.00",
        "called_up_share_capital": "1500100.00",
        "profit_loss_account_reserve": "-82880.00",
        "shareholder_funds": "1417220.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2012.zip"
      }
    ],
    "pdf_only_filings": [
      {
        "made_up_date": "2017-12-31",
        "filing_date": "2018-10-02",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-small",
        "paper_filed": true,
        "pdf_url": "/company/07650983/accounts/2017-12-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07650983/filing-history/MzIxNTg5ODU3OGFkaXF6a2N4/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2016-12-31",
        "filing_date": "2017-09-11",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-small",
        "paper_filed": true,
        "pdf_url": "/company/07650983/accounts/2016-12-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07650983/filing-history/MzE4NTAxMjA4MGFkaXF6a2N4/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2015-12-31",
        "filing_date": "2016-09-21",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-small",
        "paper_filed": true,
        "pdf_url": "/company/07650983/accounts/2015-12-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07650983/filing-history/MzE1NzY0NDU5NmFkaXF6a2N4/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2014-12-31",
        "filing_date": "2015-07-02",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-small",
        "paper_filed": true,
        "pdf_url": "/company/07650983/accounts/2014-12-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07650983/filing-history/MzEyNjEzMTM3OWFkaXF6a2N4/document?format=pdf&download=0"
      }
    ],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07650983/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-06-14",
    "last_made_up": "2026-05-31"
  },
  "officers": [],
  "psc": [
    {
      "name": "Mr Qianyi Huang",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/4048973",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent-as-firm"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": "2022-02-09",
      "nationality": "Chinese",
      "country_of_residence": "China",
      "source": "snapshot"
    },
    {
      "name": "Dr Zhao Ding",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/5330963",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent-as-firm"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": null,
      "nationality": "Chinese",
      "country_of_residence": "China",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-29T20:59:03.591456+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}